PKD1 gene therapy(Helex Inc)

N/A

Report date: 2025/11/06 10:51:28

Base Information

Drug NamePKD1 gene therapy(Helex Inc)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionPolycystin-1 gene transference
TargetsPolycystin-1
Therapy Area/IndicationsPolycystic Kidney, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelex Inc
China Registration ClassN/A

Develop Information

Active CompaniesHelex Inc
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A